Latest news from NICE

The National Institute for Health and Care Excellence (NICE) is an executive non-departmental public body sponsored by Department of Health in the United Kingdom, which publishes guidelines on the use of health technologies within the NHS (such as the use of new and existing medicines, treatments and procedures), clinical practice (guidance on the appropriate treatment and care of people with specific diseases and conditions), guidance for public sector workers on health promotion and ill-health avoidance, guidance for social care services and users. These appraisals are based primarily on evaluations of efficacy and cost–effectiveness in various circumstances. NICE was established in an attempt to end the so-called postcode lottery of healthcare in England and Wales, where treatments that were available depended upon the NHS Health Authority area in which the patient happened to live, but it has since acquired a high reputation internationally as a role model for the development of clinical guidelines. One aspect of this is the explicit determination of cost–benefit boundaries for certain technologies that it assesses. NICE also plays an important role in pioneering technology assessment in other healthcare systems through NICE International, established in May 2008 to help cultivate links with foreign governments.

Long term benefit of neuroblastoma treatment is too uncertain, says NICE

Evidence suggests dinutuximab beta (Qarziba, EUSA Pharma) could increase overall survival compared with current treatment, but there is still substantial uncertainty about its long-term benefits. Because dinutuximab beta has promising clinical benefit, the NICE appraisal committee would like to recommend it for managed access in the Cancer Drugs Fund (CDF). […]

10,000 more women to be offered test to identify the cause of heavy periods

  The update makes new recommendations for diagnosing and treating the condition, which is estimated to affect around a quarter of women of a reproductive age.  The guideline recommends that women with symptoms and/or risk factors for gynaecological diseases or conditions, such as persistent bleeding between periods, should be offered hysteroscopy. […]